Board Meetings
| Company | Meeting | Agenda | Details | Listed |
|---|---|---|---|---|
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the Unaudited Financial Results for the quarter and half year ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial ResultsOther Business | To consider and approve the financial results for the period ended September 30, 2026 and other business matters | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial ResultsDividend | Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( SEBI LODR Regulations, 2015 ), we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, the 23rd day of October, 2026, inter alia, to:1. Consider and approve the Un-Audited Standalone and Consolidated Financial Results of the Company for the quarter and six months ended September 30, 2026;2. Consider the declaration of Interim Dividend, if any, for the financial year 2026-27. | |||
Financial Results | To consider and approve the financial results for the quarter and half year ended September 30, 2026. | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial ResultsDividendOther Business | To consider and approve the financial results for the period ended September 30, 2026, dividend and other business matters | |||
Financial Results | To consider and approve the financial results for the second quarter and half year ended September 30, 2026 | |||
Financial Results | the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and half year ended on 30-Sep-26. | |||
Other Business | To consider other business matters | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | TruAlt Bioenergy Limited has informed the Exchange about Board Meeting to be held on October 23, 2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarter and half year ended September 2026 | |||
Financial ResultsOther Business | To consider and approve the financial results for the quarter and half year ending September 30, 2026 and other general business matters | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the unaudited financial results of the Company for the quarter and ninemonths ended 30 September 2026. | |||
| Chembond Chemicals Ltd | Financial Results | To consider and approve the Unaudited financial results for the period ended September 30, 2026 | ||
Financial Results | To consider and approve the financial results for the quarter and half year ended September 30, 2026 | |||
Financial ResultsOther Business | To consider and approve the financial results (standalone and consolidated) for the period ended September 30, 2026 and other business matters | |||
Financial Results | To consider and approve the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended September 30, 2026 | |||
Financial ResultsOther Business | Lumax Auto Technologies Limited has informed the Exchange about Board Meeting to be held on October 24, 2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the 2nd Quarter and Half Year ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the Un-audited Financial Results for the quarter and half-year ended September 30, 2026 | |||
Financial ResultsOther Business | To consider and approve the unaudited financial results for the Quarter and Half Year ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | Pursuant to the provisions of the Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, October 26, 2026, inter alia, to consider and approve the Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter and half year ended September 30, 2026.Further, in continuation to our earlier intimation dated September 26, 2026 regarding closure of Trading Window, we wish to inform you that the Trading Window for dealing in the shares of the Company shall remain closed from October 1, 2026 to October 28, 2026 (both days inclusive). | |||
Financial Results | To consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026 | |||
Financial Results | To consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter and half year ending September 30, 2026. | |||
Financial ResultsOther Business | Intimation of Board Meeting scheduled to be held on Monday, October 26, 2026, inter- alia, to consider and approve the Un-audited Financial Results (Standalone and Consolidated) for the 2nd Quarter and Half Year ended September 30, 2026. | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026 | |||
Financial Results | Disclosure under Regulation 29 and 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding Intimation of Board Meeting and Earnings Call | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial ResultsOther Business | To consider and approve the financial results for the quarter and half year ended September 30, 2026 and other business matters | |||
Financial Results | To consider and approve the un-audited financial results for the period ended September 30, 2026 |
Board meetings explained
What is a board meeting intimation?
Does a scheduled board meeting mean the decision will happen?
How far in advance are board meetings announced?
Can a company change or cancel the meeting date?
Why does one meeting show several agenda items?
What does "Other business matters" mean?
How is this different from the corporate actions calendar?
What does the "Listed" date mean?
How often is this calendar updated?
About this calendar
This page tracks board meetings that NSE listed companies have intimated to the exchange in advance — the meeting date, and what the board has said it will consider. Agendas include quarterly and annual financial results, fund raising, dividends, buybacks, bonus issues, stock splits, voluntary delisting, and general business. Where a company has filed a description of the business to be transacted, it is shown in its own words rather than summarised.
A scheduled meeting is a plan, not an outcome. A board that meets to consider fund raising may approve it, change it or decide against it, and companies do reschedule their own meetings. Once a decision is taken and carries an ex-date, it appears on the corporate actions calendar instead. Filter by date range or agenda, search for a company by name or symbol, or sign in to narrow the calendar to your own watchlist or portfolio.